Artrya Limited
Prices may be delayed up to 20 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| AYA.AX | EVH | EIQ.AX | 0EL.F | PHR | ALC.AX | |
|---|---|---|---|---|---|---|
| Market cap | 574.14M | 542.68M | 385.25M | 336.54M | 818.10M | 155.23M |
| P/E (TTM) | — | — | — | 33.0 | 77.5 | — |
| Forward P/E | -30.6 | 11.9 | -30.9 | — | 8.2 | 34.6 |
| Price/book | 7.3 | 1.4 | 28.9 | 0.7 | 2.2 | 1.7 |
| Dividend yield | — | — | — | 1.42% | — | — |
| 1-year change | +2.77% | −32.28% | +164.10% | −49.68% | −46.05% | +15.38% |
| Today | +4.79% | +11.63% | +0.97% | +2.48% | +7.77% | +9.52% |
The closest companies by business and industry (Health Information Services). Prices may be delayed up to 20 min.
Latest news
All AYA.AX news ›Artrya Limited (AYAUF) Q1 2027 Earnings Call Transcript
Artrya Limited (AYAUF) Q1 2027 Earnings Call October 25, 2026 8:01 PM EDT John Konstantopoulos - Co-Founder & CEOClayton Hatch - Chief Financial Officer David Allen - Hawkesbury Partners Pty Limited Now I'd like to hand over to John…
Which ASX Growth Stocks With High Insider Ownership Are Worth Watching, Including Artrya (ASX:AYA)?
Artrya develops and commercialises an artificial intelligence platform for detecting, diagnosing and addressing coronary artery disease, within the ASX Healthcare Stocks category. It earns only a very small amount from its image analysis…
From the 4Search news index, newest first.
In the news
Mentioned with
People in the coverage
Most coverage from
- kalkinemedia.com1
- seekingalpha.com1
Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 2 articles, not a forecast.